Terri Gaskell

Terri Gaskell

Company: Rinri Therapeutics

Job title: CTO

Seminars:

Panel Discussion & Live Audience Q&A: Is 2025 the Year of Curing Deafness? Reviewing Past Failures, Recent Successes & Future Opportunities for Inner Ear Disorders Therapeutics 8:00 am

Discussing the back-to-back positive results for gene therapies, large investments from key pharma into the inner ear disorders field, and uncovering the opportunities for 2024 and 2025 Leveraging lessons from past failures and understanding their downfalls Understanding the current challenges with novel targets, preclinical models replicating the inner ear structures, less invasive delivery mechanisms and…Read more

day: Conference Day 1

Developing a Regenerative Cell Therapy for Hearing Loss: From Early Research to Clinical Readiness 11:15 am

Generating a comprehensive preclinical safety and efficacy data package Optimising manufacturing and establishing a GMP process Developing novel surgical approaches and clinical endpoints for FiH trial Gaining positive feedback from regulators supporting our translational approachRead more

day: Conference Day 1

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.